PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing


PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today announced that it has filed a provisional patent application with the United States Patent and Trademark Office to protect its therapy to treat cancerous tumors, including the therapy that will be used in its upcoming clinical trial in locally advanced pancreas cancer .



from Biotech News